Infections Simulating Immune Checkpoint Inhibitor Toxicities: Uncommon and Deceptive

Resource type
Journal Article
Authors/contributors
Title
Infections Simulating Immune Checkpoint Inhibitor Toxicities: Uncommon and Deceptive
Abstract
Abstract Use of immune checkpoint inhibitors (ICIs), a revolutionary treatment in modern oncology, is frequently complicated by immune-related adverse events (irAEs), which can be confused with infections, and vice versa, thus complicating management decisions. In this study, we review the published cases of infections as simulators of irAEs in cancer patients.
Publication
Open Forum Infectious Diseases
Date
2022-11-02
Volume
9
Issue
11
Pages
ofac570
Accessed
12/2/22, 3:08 PM
ISSN
2328-8957
Short Title
Infections Simulating Immune Checkpoint Inhibitor Toxicities
Language
en
Library Catalog
DOI.org (Crossref)
Citation
Gudiol, C., Hicklen, R. S., Okhyusen, P. C., Malek, A. E., & Kontoyiannis, D. P. (2022). Infections Simulating Immune Checkpoint Inhibitor Toxicities: Uncommon and Deceptive. Open Forum Infectious Diseases, 9(11), ofac570. https://doi.org/10.1093/ofid/ofac570
HEME-ONC AND CELLULAR THERAPIES
Link to this record